CYTEIR THERAPEUTICS INC (CYT)
US23284P1030 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -33.21M | -46.06M | -42.13M | -20.82M | -15.04M | |||
| Depreciation Amortization | 540.00K | 670.00K | 480.00K | 350.00K | 220.00K | |||
| Change In Working Capital | 2.68M | -2.53M | 2.15M | 1.47M | -2.16M | |||
| Other non cash items | 4.21M | 5.39M | 3.47M | 470.00K | -570.00K | |||
| OPERATING CASH FLOW | -25.78M | -42.53M | -36.03M | -18.54M | -17.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -310.00K | -1.19M | -850.00K | -130.00K | |||
| INVESTING CASH FLOW | 300.00K | -310.00K | -1.19M | -850.00K | -130.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 840.00K | 240.00K | 216.01M | 1.43M | 36.89M | |||
| FINANCING CASH FLOW | 840.00K | 240.00K | 216.01M | 1.43M | 36.89M | |||
| CHANGE IN CASH | -24.64M | -42.60M | 178.79M | -17.96M | 19.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.78M | -42.53M | -36.03M | -18.54M | -17.56M | |||
| Capital Expenditure | 0.00 | -310.00K | -1.19M | -850.00K | -130.00K | |||
| FREE CASH FLOW | -25.78M | -42.84M | -37.22M | -19.39M | -17.69M | |||
All data in USD